ONCC Chemotherapy Administration and Safety 3

Question 1

A patient is prescribed oral capecitabine (Xeloda). Which teaching point is MOST important for this patient?

Accepted Answer

Take with food within 30 minutes after meals and report hand-foot syndrome immediately

Answer

Take the medication on an empty stomach for best absorption

Answer

Double the dose if a dose is missed

Answer

It is safe to take with grapefruit juice

Question 2

Which of the following chemotherapy agents is classified as a vesicant and requires a central venous access device for safe administration?

Accepted Answer

Doxorubicin

Answer

Cyclophosphamide

Answer

Carboplatin

Answer

Bevacizumab

Question 3

The nurse notes that a chemotherapy bag label does not match the patient's armband. What is the correct action?

Accepted Answer

Do not administer and resolve the discrepancy through proper verification channels before proceeding

Answer

Administer the drug since the oncologist ordered it

Answer

Ask a colleague if it looks right and proceed

Answer

Check the previous nurse's notes to confirm

Question 4

A patient receiving IV oxaliplatin complains of acute throat tightening and difficulty swallowing cold liquids. The nurse should:

Accepted Answer

Educate the patient that this is a known cold-induced peripheral neuropathy and advise avoiding cold temperatures

Answer

Stop the infusion and administer emergency epinephrine

Answer

Increase the infusion rate

Answer

Administer an antiemetic and reassure the patient

Question 5

During irinotecan infusion, a patient develops acute onset of diarrhea, diaphoresis, and abdominal cramping. Which agent should the nurse administer?

Accepted Answer

Atropine

Answer

Loperamide

Answer

Diphenhydramine

Answer

Ondansetron

Question 6

A nurse is calculating the dose of carboplatin using the Calvert formula. Which two values are essential inputs?

Accepted Answer

Target AUC and the patient's glomerular filtration rate (GFR)

Answer

Body surface area and age

Answer

Weight in kg and serum sodium

Answer

Height and serum albumin

Question 7

A patient receiving trastuzumab (Herceptin) should be monitored for which serious cardiac toxicity?

Accepted Answer

Cardiomyopathy and decreased left ventricular ejection fraction (LVEF)

Answer

Pericardial effusion

Answer

Cardiac arrhythmia only

Answer

Hypertensive crisis